Daxor Corp DXR
$10.50
▼ -0.28%
($-0.03)
🎈 Low Float
Open
$10.50
Prev Close
$10.53
Day Range
$10.50 – $10.50
52W Range
$8.56 – $14.76
Market Cap
$61.48M
P/E (TTM)
7.14
Beta
0.24
EPS (TTM)
$1.98
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 1983-07-25 |
| Shares Out. | 5,840,000 |
| Website | daxor.com/ ↗ |
| Phone | 18654250555 |
| Employees | 750 |
| Revenue | $369,830 |
| Gross Profit | $192,876 |
| Net Income | -$1.5M |
| Total Assets | $85.7M |
| Total Liabilities | $49.5M |
| Equity | $36.2M |
About Daxor Corp
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA offers unmatched, real-time, precise data via its rapid, hand-held, lab-based system.
Daxor Corp is a publicly traded company under the ticker symbol DXR on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
6 analysts (2026-07-01)